Metabolic dysfunction-associated steatotic liver disease and risk of four intrahepatic and extrahepatic diseases Yiyuan Xiao; Wenyan Hu; Jiapeng Huang; Sihua Xu; Deke Jiang; Rong Na; Zhaoqing Yin; Jingjing Zhang; Haitao Chen;

Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study Samantha Thifani Alrutz Barcelos; Amanda Souza Silva-Sperb; Helena Abadie Moraes; Larisse Longo; Bruna Concheski de Moura; Matheus Truccolo Michalczuk; Carolina Uribe-Cruz; Carlos Thadeu Schmidt Cerski; Themis Reverbel da Silveira; Valesca Dall'Alba; Mário Reis Álvares-da-Silva;

The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based study Osama Hamid; Ahmed Eltelbany; Abdul Mohammed; Khaled Alsabbagh Alchirazi; Sushrut Trakroo; Imad Asaad;